The development of an inducible androgen receptor knockout model in mouse to study the postmeiotic effects of androgens on germ cell development

Ariane Willems, Karel De Gendt, Lodewijk Deboel, Johannes V Swinnen, Guido Verhoeven

Research output: Contribution to journalArticle

4 Downloads (Pure)

Abstract

A mouse model with a Sertoli cell (SC)-selective ablation of the androgen receptor (AR)-the SCARKO mouse-demonstrated that the effects of androgens on spermatogenesis depend on the presence of an active AR in SC. This model has been extremely valuable in the study of the effects of androgens on the initiation of spermatogenesis. However, due to the early (prenatal) inactivation of the AR SCARKO mice develop a complete block in meiosis, making it impossible to study the effects of androgens on postmeiotic steps of germ cell development. It would therefore be of interest to develop a model in which the AR can be ablated at any chosen time point. Here we used a mouse line ubiquitously expressing a tamoxifen (TM)-inducible Cre recombinase to develop an inducible AR knockout model (iARKO). It is shown that treatment with TM (3 mg/day) for five consecutive days efficiently inactivates the AR in testicular tissue and decreases the expression of known AR-target genes in SC (Rhox5, Spinlw1) without markedly affecting testicular cell composition one day after the final injection. TM treatment did, however, decrease serum gonadotropin levels and the expression of several Leydig cell genes (StAR, Cyp17a1, Insl3), resulting in decreased testosterone levels. Nevertheless, the intratesticular testosterone concentration still far exceeds the estimated concentrations required to saturate the AR. It may be concluded that the study of androgen-responsive postmeiotic genes in SC may be feasible using a TM-inducible AR knockout model provided that appropriate controls are included correcting for off-target effects of TM.
Original languageEnglish
Pages (from-to)341-353
Number of pages13
JournalSpermatogenesis
Volume1
Issue number4
DOIs
Publication statusPublished - 2011

Fingerprint

Androgen Receptors
Germ Cells
Androgens
Tamoxifen
Sertoli Cells
Spermatogenesis
Testosterone
Genes
Leydig Cells
Meiosis
Gonadotropins
Injections
Therapeutics
Serum

Keywords

  • androgen action
  • inducible knockout
  • spermatogenesis
  • tamoxifen
  • transgenesis

Cite this

The development of an inducible androgen receptor knockout model in mouse to study the postmeiotic effects of androgens on germ cell development. / Willems, Ariane; De Gendt, Karel; Deboel, Lodewijk; Swinnen, Johannes V; Verhoeven, Guido.

In: Spermatogenesis, Vol. 1, No. 4, 2011, p. 341-353.

Research output: Contribution to journalArticle

Willems, Ariane ; De Gendt, Karel ; Deboel, Lodewijk ; Swinnen, Johannes V ; Verhoeven, Guido. / The development of an inducible androgen receptor knockout model in mouse to study the postmeiotic effects of androgens on germ cell development. In: Spermatogenesis. 2011 ; Vol. 1, No. 4. pp. 341-353.
@article{5ee4afeb3d2045db958ddd0bca4e18a1,
title = "The development of an inducible androgen receptor knockout model in mouse to study the postmeiotic effects of androgens on germ cell development",
abstract = "A mouse model with a Sertoli cell (SC)-selective ablation of the androgen receptor (AR)-the SCARKO mouse-demonstrated that the effects of androgens on spermatogenesis depend on the presence of an active AR in SC. This model has been extremely valuable in the study of the effects of androgens on the initiation of spermatogenesis. However, due to the early (prenatal) inactivation of the AR SCARKO mice develop a complete block in meiosis, making it impossible to study the effects of androgens on postmeiotic steps of germ cell development. It would therefore be of interest to develop a model in which the AR can be ablated at any chosen time point. Here we used a mouse line ubiquitously expressing a tamoxifen (TM)-inducible Cre recombinase to develop an inducible AR knockout model (iARKO). It is shown that treatment with TM (3 mg/day) for five consecutive days efficiently inactivates the AR in testicular tissue and decreases the expression of known AR-target genes in SC (Rhox5, Spinlw1) without markedly affecting testicular cell composition one day after the final injection. TM treatment did, however, decrease serum gonadotropin levels and the expression of several Leydig cell genes (StAR, Cyp17a1, Insl3), resulting in decreased testosterone levels. Nevertheless, the intratesticular testosterone concentration still far exceeds the estimated concentrations required to saturate the AR. It may be concluded that the study of androgen-responsive postmeiotic genes in SC may be feasible using a TM-inducible AR knockout model provided that appropriate controls are included correcting for off-target effects of TM.",
keywords = "androgen action, inducible knockout, spermatogenesis, tamoxifen, transgenesis",
author = "Ariane Willems and {De Gendt}, Karel and Lodewijk Deboel and Swinnen, {Johannes V} and Guido Verhoeven",
year = "2011",
doi = "10.4161/spmg.1.4.18740",
language = "English",
volume = "1",
pages = "341--353",
journal = "Spermatogenesis",
issn = "2156-5562",
publisher = "Taylor and Francis Ltd.",
number = "4",

}

TY - JOUR

T1 - The development of an inducible androgen receptor knockout model in mouse to study the postmeiotic effects of androgens on germ cell development

AU - Willems, Ariane

AU - De Gendt, Karel

AU - Deboel, Lodewijk

AU - Swinnen, Johannes V

AU - Verhoeven, Guido

PY - 2011

Y1 - 2011

N2 - A mouse model with a Sertoli cell (SC)-selective ablation of the androgen receptor (AR)-the SCARKO mouse-demonstrated that the effects of androgens on spermatogenesis depend on the presence of an active AR in SC. This model has been extremely valuable in the study of the effects of androgens on the initiation of spermatogenesis. However, due to the early (prenatal) inactivation of the AR SCARKO mice develop a complete block in meiosis, making it impossible to study the effects of androgens on postmeiotic steps of germ cell development. It would therefore be of interest to develop a model in which the AR can be ablated at any chosen time point. Here we used a mouse line ubiquitously expressing a tamoxifen (TM)-inducible Cre recombinase to develop an inducible AR knockout model (iARKO). It is shown that treatment with TM (3 mg/day) for five consecutive days efficiently inactivates the AR in testicular tissue and decreases the expression of known AR-target genes in SC (Rhox5, Spinlw1) without markedly affecting testicular cell composition one day after the final injection. TM treatment did, however, decrease serum gonadotropin levels and the expression of several Leydig cell genes (StAR, Cyp17a1, Insl3), resulting in decreased testosterone levels. Nevertheless, the intratesticular testosterone concentration still far exceeds the estimated concentrations required to saturate the AR. It may be concluded that the study of androgen-responsive postmeiotic genes in SC may be feasible using a TM-inducible AR knockout model provided that appropriate controls are included correcting for off-target effects of TM.

AB - A mouse model with a Sertoli cell (SC)-selective ablation of the androgen receptor (AR)-the SCARKO mouse-demonstrated that the effects of androgens on spermatogenesis depend on the presence of an active AR in SC. This model has been extremely valuable in the study of the effects of androgens on the initiation of spermatogenesis. However, due to the early (prenatal) inactivation of the AR SCARKO mice develop a complete block in meiosis, making it impossible to study the effects of androgens on postmeiotic steps of germ cell development. It would therefore be of interest to develop a model in which the AR can be ablated at any chosen time point. Here we used a mouse line ubiquitously expressing a tamoxifen (TM)-inducible Cre recombinase to develop an inducible AR knockout model (iARKO). It is shown that treatment with TM (3 mg/day) for five consecutive days efficiently inactivates the AR in testicular tissue and decreases the expression of known AR-target genes in SC (Rhox5, Spinlw1) without markedly affecting testicular cell composition one day after the final injection. TM treatment did, however, decrease serum gonadotropin levels and the expression of several Leydig cell genes (StAR, Cyp17a1, Insl3), resulting in decreased testosterone levels. Nevertheless, the intratesticular testosterone concentration still far exceeds the estimated concentrations required to saturate the AR. It may be concluded that the study of androgen-responsive postmeiotic genes in SC may be feasible using a TM-inducible AR knockout model provided that appropriate controls are included correcting for off-target effects of TM.

KW - androgen action

KW - inducible knockout

KW - spermatogenesis

KW - tamoxifen

KW - transgenesis

U2 - 10.4161/spmg.1.4.18740

DO - 10.4161/spmg.1.4.18740

M3 - Article

VL - 1

SP - 341

EP - 353

JO - Spermatogenesis

JF - Spermatogenesis

SN - 2156-5562

IS - 4

ER -